EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Congenital CMV Infection: Determination of Transplacental Passage of Aciclovir by Ex Vivo Placental Perfusion

Helyett Ollivier iD, Valentine Faure Bardon iD, Leo Froelicher Bournaud, Isidore Gaubert, Tiffany Guilleminot, Marianne Leruez-Ville, Jean-Marc Treluyer, Yves Ville, Gabrielle Lui, Julien Stirnemann

BJOG: An International Journal of Obstetrics & Gynaecology · 2026

DOI: 10.1111/1471-0528.70168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2026. Verfasst von Helyett Ollivier und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Medicine and Obstetric Department, APHP, Necker-Enfants Malades Hospital, Paris, France. Hauptthemen laut MEDLINE: Acyclovir, Antiviral Agents, Placenta, Maternal-Fetal Exchange. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To quantify the transplacental transfer of aciclovir at an amount equivalent to 2 g of valaciclovir corresponding to the fractionated dosing regimen given four times daily used to reduce congenital cytomegalovirus (CMV) transmission and to treat the CMV‐infected fetus.

Design

Experimental ex vivo study.

Setting

Dual closed‐loop perfusion of isolated human placental cotyledons. Population Placentas collected at term.

Methods

Placental transfer was assessed using the dual closed‐loop ex vivo perfusion. Aciclovir was perfused in the maternal compartment at a concentration corresponding to the oral dose of 2 g of valaciclovir taken every 6 h (8 g/day). Samples from maternal and fetal compartments were collected at regular intervals over a 3‐h period. Aciclovir concentrations were measured using chromatographic techniques. The transfer rate was calculated as the ratio of the number of moles of fetal aciclovir to the number of fetal and maternal moles at 3 h.

Results

Nine perfusion experiments met the criteria for success and could be used for interpretation. The mean transplacental transfer rate of aciclovir was 17.4% (SD: 7.8%). With a single 2 g dose, fetal exposure to aciclovir remained below the IC50 for CMV.

Conclusion

The transplacental transfer of aciclovir is low. Despite aciclovir's low molecular weight and hydrophilicity, moderate plasma protein binding and rapid renal elimination may limit placental availability, and the observed transfer was lower than expected for passive diffusion, suggesting involvement of facilitated uptake or efflux mechanisms. These results support the current rationale for high‐dose valaciclovir regimens in pregnancy and suggest a potential role for transporter‐mediated drug transfer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcyclovirAntiviral AgentsPlacentaMaternal-Fetal ExchangeCytomegalovirus InfectionsPregnancy Complications, InfectiousHumansFemalePregnancyPerfusionValacyclovirInfectious Disease Transmission, VerticalValine

Stichwörter der Autor:innen

aciclovircongenital CMVfetal therapyplacental perfusionplacental transfervalaciclovir

Substanzen

AcyclovirAntiviral AgentsValacyclovirValine

Autor:innen und Institutionen

  • Fetal Medicine and Obstetric Department, APHP, Necker-Enfants Malades Hospital, Paris, France.
  • Department of Obstetrics and Gynecology, Groupe Hospitalier Pitié Salpêtrière, Université Pierre et Marie Curie-Paris 6, Paris, France.
  • Pharmacology and Therapeutic Evaluation in Children and Pregnant Women, Paris Cité University, Inserm, Paris, France.
  • Perinatal, Pediatric, and Adult Pharmacology Department, Cochin Hospital, Georges Pompidou European Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
  • CNRS, Institut Galien Paris-Saclay, Université Paris-Saclay, Orsay, France.
  • URP7328, Federation for Research Into Innovative Explorations an Therapeutics in Utero Paris, URP 7328, University of Paris Cité, Paris, France.

ORCID-Profile: Helyett Ollivier, Valentine Faure Bardon

Zitieren

APA

Ollivier, H., Bardon, V. F., Bournaud, L. F., Gaubert, I., Guilleminot, T., Leruez-Ville, M., Treluyer, J. M., Ville, Y., Lui, G., & Stirnemann, J. (2026). Congenital CMV Infection: Determination of Transplacental Passage of Aciclovir by Ex Vivo Placental Perfusion. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.70168

Vancouver

Ollivier H, Bardon VF, Bournaud LF, Gaubert I, Guilleminot T, Leruez-Ville M, et al. Congenital CMV Infection: Determination of Transplacental Passage of Aciclovir by Ex Vivo Placental Perfusion. BJOG: An International Journal of Obstetrics & Gynaecology. 2026. doi:10.1111/1471-0528.70168

BibTeX
@article{Ollivier2026,
  author = {Ollivier, Helyett and Bardon, Valentine Faure and Bournaud, Leo Froelicher and Gaubert, Isidore and Guilleminot, Tiffany and Leruez-Ville, Marianne and Treluyer, Jean-Marc and Ville, Yves and Lui, Gabrielle and Stirnemann, Julien},
  title = {Congenital CMV Infection: Determination of Transplacental Passage of Aciclovir by Ex Vivo Placental Perfusion},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2026},
  doi = {10.1111/1471-0528.70168}
}
Kostenlos starten →